Measurement of total and diffusible serum fluoride

Journal of Clinical Laboratory Analysis

Volumn 13, Issue 4, 1999, Pages 151-157

  Rigalli, Alfredo ^a   Alloatti, Rosa ^a   Puche, Rodolfo C ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Bone mass; Osteoporosis; Serum fluoride protein bound

Indexed keywords

FLUORIDE; FLUORIDE SODIUM;

ADULT; ARTICLE; BLOOD SAMPLING; BONE MASS; CONTROLLED STUDY; DRUG DETERMINATION; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; OSTEOPOROSIS;

AGED; BLOOD PROTEINS; DIFFUSION; ELECTRODES; FASTING; FEMALE; FLUORIDES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHOSPHATES; PROTEIN BINDING; SENSITIVITY AND SPECIFICITY; SODIUM FLUORIDE;

EID: 0033033746     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1999)13:4<151::AID-JCLA3>3.0.CO;2-A     Document Type: Article

References (32)

1. Taves DR. New approach to the treatment of bone disease with fluoride. Fed Proc 1970;29:1185-87.
2. Taves DR. Electrophoretic mobility of serum fluoride. Nature 1968;220:582-583.
3. Tave DR. Evidence that there are two forms of fluoride in human serum. Nature 1968;217:1050-1051.
4. Singer L, Armstrong WD. Total fluoride content of human serum. Arch Oral Biol 1969;14:1343-1347.
5. Venkateswarlu P, Singer L, Armstrong WD. Determination of diffusible (plus ionizable) fluoride in biological fluids. Anal Biochem 1971;42:350-359.
6. Lau KHW, Farley JR, Freeman TK, Baylink DJ. A proposed mechanism of the mitogenic action of fluoride on bone cells: inhibition of the activity of an osteoblastic acid phosphatase. Metabolism 1989;38:858-868.
7. Rigalli A, Esteban L, Pera L, Puche RC. Binding of monofluorophosphate to α2-macroglobulin and C3. Calcif Tissue Int 1997;60:86-89.
8. Rigalli A, Cabrerizo MA, Beinlich AD, Puche RC. Gastric and intestinal absorption of monofluorophosphate and fluoride in the rat. Fortschr Arzneimittelforsch 1994;44:651-655.
9. Rigalli A, Morosano M, Puche RC. Bioavailability of fluoride administered as sodium fluoride or sodium monofluorophosphate to human volunteers. Fortschr Arzneimittelforsch 1996;46:531-533.
10. Orion Research Inc. Cambridge, Mass. Form IM94,96/2840.
11. Taves DR. Determination of submicromolar concentrations of fluoride in biological samples. Talanta 1968;15:1015-1023.
12. The United States Pharmacopeia. The National Formulary, United Sates Pharmacopeial Convention Inc., Rockville, MD; 1990.
13. Hallsworth AS, Weatherell JA, Deutsch D. Determination of subnanogram amounts of fluoride with the fluoride electrode. Anal Chem 1976;48:1660-64.
14. NCCLS Tentative Guideline EP5-T. User evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards; 1984.
15. Clark LC, Thompson HL. Determination of creatinine. Anal Chem 1949;17:6-10.
16. Snedecor GW, Cochran WG. Statistical Methods. Ames: Iowa State University Press, 1967.
17. Guy WS. Inorganic and organic fluoride in human blood. In: Johansen T, Taves D, Olsen B, editors. Continuing evaluation of the use of fluorides. AAAS Selected Symposium Series 11:125-147; Boulder, CO: Westview; 1967.
18. Guy WS, Taves DR, Brey WS Jr. Organic fluorocompounds human serum; prevalence and characterization. In: Filler W, editor. Biochemistry involving carbon-fluorine bonds. Am Chem Soc Symp Ser 1977;28:117-134.
19. Chen PS Jr, Smith FA, Gardner DE, O'Brien JA, Hodge HC. Renal clearance of fluoride. Proc Soc Exp Biol Med 1956;92:879-883.
20. Ekstrand J. A micromethod for the determination of fluoride in blood serum and saliva. Calcif Tissue Res 1977;23:225-228.
21. Cox FH, Dirks BO. The determination of fluoride in blood serum. Caries Res 1968;2:69-78.
22. Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 1993;3:322-329.
23. Battmann A, Resch H, Libanati CR, et al. Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: comparison with plain monofluorophosphate. Osteoporos Int 1997;7:48-51.
24. Mamelle N, Dusan R, Martin JL, et al. Risk benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988;13:361-365.
25. Fry BW, Taves DR. Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 1970;75:1020-1025.
26. Fuchs C, Dorn D, Fuchs CA, et al. Fluoride determination in serum by ion selective electrode: a simplified method for the clinical laboratory. Clin Chim Acta 1975;60:157-167.
27. Whitford GM, Pashley DJ, Stringer GI. Fluoride renal clearance: a pH dependent event. Am J Physiol 1976;230:527-532.
28. Waterhouse C, Taves D, Munzer A. Serum inorganic fluoride: changes related to previous fluoride intake, renal function and bone resorption. Clin Sci 1980;58:145-152.
29. Ekstrand J. Relationship between fluoride and the drinking water and the serum fluoride concentration in man. Caries Res 1978;12:123-127.
30. Cowell DC, Taylor WH. Diffusible fluoride: a study of its physiological variation in man. Ann Clin Biochem 1981;18:76-831.
31. Husdan H, Vogl R, Oreopoulos D, Gryfe C, Rapport A. Serum diffusible fluoride: normal range and relationship to age and sex. Clin Chem 1976;22:1884-1888.
32. Singer L, Orphaug RH. Concentrations of diffusible, total and bound fluoride in serum. Clin Chem 1979;25:523-25.